3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Breast Neoplasms
523
Leukemia, Myeloid, Acute
499
Neoplasms
381
Carcinoma, Non-Small-Cell Lung
381
Pancreatic Neoplasms
329
Precursor Cell Lymphoblastic Leukemia-Lymphoma
319
Multiple Myeloma
312
Glioblastoma
311
Melanoma
310
Prostatic Neoplasms
293
Leukemia
289
Neoplasm Metastasis
284
Brain Neoplasms
277
Lymphoma
271
Lung Neoplasms
270
Recurrence
267
Ovarian Neoplasms
247
Colorectal Neoplasms
246
Lymphoma, Non-Hodgkin
242
Leukemia, Lymphocytic, Chronic, B-Cell
231
Glioma
209
Myelodysplastic Syndromes
208
Lymphoma, Large B-Cell, Diffuse
186
Carcinoma, Hepatocellular
173
Lymphoma, Follicular
167
Head and Neck Neoplasms
162
Hodgkin Disease
160
Lymphoma, Mantle-Cell
155
Burkitt Lymphoma
154
Sarcoma
150
Interventions
temsirolimus
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
OTHER
×
Patients With Advanced or Metastatic Solid Tumors
×
Clear all
NCT02215720
2026-03-20
TORERO
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1
Completed
45 enrolled